Company Filing History:
1 out of 19 
1 out of 1,929 
Years Active: 2016
Title: Anjan Nan: Innovator in Cancer Treatment
Introduction
Anjan Nan is a notable inventor based in Hanover, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Anjan Nan holds a patent for "HPMA—docetaxel conjugates and uses therefore." This patent discloses water-soluble compositions of gemcitabine and docetaxel formed by conjugating these compounds to a water-soluble polymer such as N-2-hydroxypropyl methacrylamide (HPMA). The invention also includes methods for using these compositions in the treatment of cancer. He has 1 patent to his name.
Career Highlights
Throughout his career, Anjan Nan has worked with prominent organizations, including Rexahn Pharmaceuticals, Inc. and the University System of Maryland. His work has focused on developing innovative solutions for cancer therapies.
Collaborations
Anjan has collaborated with esteemed colleagues such as Young Bok Lee and Deog Joong Kim, contributing to advancements in his field.
Conclusion
Anjan Nan's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a significant figure in medical research. His work continues to impact the field positively.